Delivery Order SPE2DB22D3401-SPE2DB25FT0UE
- Not listed
- This federal contract award, valued at $10,594.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. It is a firm fixed-price delivery order contract with a completion date of December 2, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $3,495.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award, valued at $2,636.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 25 MG TABLET 30S, a medical product, with a completion date of January 8, 2025. This appears to be a firm fixed-price delivery order contract, with no set-aside requirements indicated. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $11,252.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. It is a Firm Fixed Price Delivery Order contract with a period of performance through January 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award, valued at $10,301.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product, with a performance period through September 20, 2023. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
- This federal contract award, valued at $15,839.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a performance period ending on July 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
- This federal contract award, valued at $11,748.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of MYRBETRIQ ER 25 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of July 11, 2024. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- This federal contract award, valued at $11,327.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 30, 2024. The contract is a firm-fixed-price delivery order for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a prescription medication, with a completion date of October 31, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $1,767.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product, with a completion date of February 21, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $3,247.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product, to be delivered by June 9, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT0UEDelivery Order
This federal contract award, valued at $2,755.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MYRBETRIQ ER 25 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of November 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 11/18/24 |